HK Stock MarketDetailed Quotes

HAICHANG HLDG (02255)

Watchlist
  • 0.435
  • 0.0000.00%
Market Closed Apr 30 15:56 CST
5.75BMarket Cap-5.44P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

HAICHANG HLDG (02255) Income Statement

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q6)Jun 30, 2025
(FY)Dec 31, 2024
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
Turnover
-14.80%1.55B
-14.19%686.3M
0.08%1.82B
6.82%799.8M
129.11%1.82B
190.47%748.73M
-67.77%792.99M
-80.54%257.76M
110.59%2.46B
306.86%1.32B
Operating income
-14.80%1.55B
-14.19%686.3M
0.08%1.82B
6.82%799.8M
129.11%1.82B
190.47%748.73M
-67.77%792.99M
-80.54%257.76M
110.59%2.46B
306.86%1.32B
Cost of sales
10.99%-1.25B
-1.60%-614.6M
-2.94%-1.4B
-10.84%-604.93M
-26.84%-1.36B
-36.48%-545.79M
38.37%-1.07B
51.84%-399.91M
-34.02%-1.74B
-55.22%-830.3M
Operating expenses
10.99%-1.25B
-1.60%-614.6M
-2.94%-1.4B
-10.84%-604.93M
-26.84%-1.36B
-36.48%-545.79M
38.37%-1.07B
51.84%-399.91M
-34.02%-1.74B
-55.22%-830.3M
Gross profit
-27.53%303.63M
-63.21%71.7M
-8.41%418.97M
-3.97%194.87M
264.12%457.46M
242.77%202.94M
-138.64%-278.73M
-128.77%-142.14M
658.02%721.27M
335.97%494.13M
Selling expenses
-5.78%-180.07M
-91.64%-51.25M
-22.27%-170.23M
-16.52%-26.74M
-63.73%-139.22M
13.71%-22.95M
62.27%-85.03M
73.33%-26.6M
-33.39%-225.37M
-76.14%-99.73M
Administrative expenses
13.58%-621.59M
-3.34%-172.53M
-53.11%-719.29M
11.46%-166.94M
22.52%-469.79M
7.72%-188.56M
47.16%-606.38M
40.00%-204.33M
-69.72%-1.15B
-14.08%-340.57M
Impairment and provision
-7,503.78%-33.32M
----
-94.44%450K
774.35%5.44M
110.60%8.09M
96.31%-807K
-292.73%-76.36M
-140.15%-21.9M
18.20%-19.44M
78.20%-9.12M
-Other impairment is provision
-7,503.78%-33.32M
----
-94.44%450K
774.35%5.44M
110.60%8.09M
96.31%-807K
-292.73%-76.36M
-140.15%-21.9M
18.20%-19.44M
78.20%-9.12M
Operating interest expense
----
----
----
----
----
----
----
----
18.18%-489.87M
5.06%-307.4M
Special items of operating profit
-380.83%-156.36M
-82.88%13.43M
-80.11%55.68M
25.76%78.48M
590.87%279.95M
7,730.11%62.41M
-102.34%-57.03M
-99.36%797K
3,027.72%2.44B
49,959.04%124.15M
Operating profit
-65.94%-687.7M
-262.90%-138.65M
-403.66%-414.42M
60.51%85.11M
112.37%136.48M
113.45%53.02M
-186.35%-1.1B
-184.54%-394.17M
184.14%1.28B
85.11%-138.53M
Financing cost
7.36%-321M
6.86%-156.97M
-7.41%-346.5M
-12.66%-168.52M
-2.45%-322.58M
2.70%-149.58M
---314.86M
---153.74M
----
----
Share of profits of associates
----
----
----
----
----
----
----
----
-6,039.68%-80.84M
-7,200.00%-146K
Earning before tax
-32.56%-1.01B
-254.41%-295.61M
-308.87%-760.92M
13.62%-83.41M
86.88%-186.1M
82.38%-96.56M
-218.48%-1.42B
-295.10%-547.91M
178.89%1.2B
85.10%-138.68M
Tax
120.29%25.13M
99.58%-16K
171.81%11.41M
-131.95%-3.79M
-55.96%4.2M
2,185.39%11.85M
102.63%9.53M
99.59%-568K
-1,028.90%-362.93M
-451.46%-139.69M
After-tax profit from continuing operations
-31.23%-983.56M
-239.05%-295.63M
-312.03%-749.51M
-2.93%-87.19M
87.09%-181.91M
84.56%-84.71M
-268.88%-1.41B
-97.03%-548.48M
156.43%834.24M
68.75%-278.37M
Earning after tax
-31.23%-983.56M
-239.05%-295.63M
-312.03%-749.51M
-2.93%-87.19M
87.09%-181.91M
84.56%-84.71M
-268.88%-1.41B
-97.03%-548.48M
156.43%834.24M
68.75%-278.37M
Minority profit
-182.75%-27.69M
83.59%-487K
-163.78%-9.79M
-169.34%-2.97M
218.58%15.35M
146.50%4.28M
-21.99%-12.95M
-715.87%-9.2M
60.42%-10.61M
92.25%-1.13M
Profit attributable to shareholders
-29.22%-955.88M
-250.41%-295.14M
-275.00%-739.72M
5.35%-84.23M
85.87%-197.26M
83.50%-88.99M
-265.23%-1.4B
-94.52%-539.27M
158.20%844.85M
68.36%-277.24M
Basic earnings per share
-14.25%-0.1042
-250.00%-0.0364
-275.31%-0.0912
5.45%-0.0104
85.96%-0.0243
83.66%-0.011
-263.92%-0.1731
3.86%-0.0673
129.10%0.1056
68.04%-0.07
Diluted earnings per share
-14.25%-0.1042
-250.00%-0.0364
-275.31%-0.0912
5.45%-0.0104
85.96%-0.0243
83.66%-0.011
-263.92%-0.1731
3.86%-0.0673
129.10%0.1056
68.04%-0.07
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
--
--
--
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Auditor
--
--
National Health Accounting Firm Co., Ltd.
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
(FY)Dec 31, 2025(Q6)Jun 30, 2025(FY)Dec 31, 2024(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021
Turnover -14.80%1.55B-14.19%686.3M0.08%1.82B6.82%799.8M129.11%1.82B190.47%748.73M-67.77%792.99M-80.54%257.76M110.59%2.46B306.86%1.32B
Operating income -14.80%1.55B-14.19%686.3M0.08%1.82B6.82%799.8M129.11%1.82B190.47%748.73M-67.77%792.99M-80.54%257.76M110.59%2.46B306.86%1.32B
Cost of sales 10.99%-1.25B-1.60%-614.6M-2.94%-1.4B-10.84%-604.93M-26.84%-1.36B-36.48%-545.79M38.37%-1.07B51.84%-399.91M-34.02%-1.74B-55.22%-830.3M
Operating expenses 10.99%-1.25B-1.60%-614.6M-2.94%-1.4B-10.84%-604.93M-26.84%-1.36B-36.48%-545.79M38.37%-1.07B51.84%-399.91M-34.02%-1.74B-55.22%-830.3M
Gross profit -27.53%303.63M-63.21%71.7M-8.41%418.97M-3.97%194.87M264.12%457.46M242.77%202.94M-138.64%-278.73M-128.77%-142.14M658.02%721.27M335.97%494.13M
Selling expenses -5.78%-180.07M-91.64%-51.25M-22.27%-170.23M-16.52%-26.74M-63.73%-139.22M13.71%-22.95M62.27%-85.03M73.33%-26.6M-33.39%-225.37M-76.14%-99.73M
Administrative expenses 13.58%-621.59M-3.34%-172.53M-53.11%-719.29M11.46%-166.94M22.52%-469.79M7.72%-188.56M47.16%-606.38M40.00%-204.33M-69.72%-1.15B-14.08%-340.57M
Impairment and provision -7,503.78%-33.32M-----94.44%450K774.35%5.44M110.60%8.09M96.31%-807K-292.73%-76.36M-140.15%-21.9M18.20%-19.44M78.20%-9.12M
-Other impairment is provision -7,503.78%-33.32M-----94.44%450K774.35%5.44M110.60%8.09M96.31%-807K-292.73%-76.36M-140.15%-21.9M18.20%-19.44M78.20%-9.12M
Operating interest expense --------------------------------18.18%-489.87M5.06%-307.4M
Special items of operating profit -380.83%-156.36M-82.88%13.43M-80.11%55.68M25.76%78.48M590.87%279.95M7,730.11%62.41M-102.34%-57.03M-99.36%797K3,027.72%2.44B49,959.04%124.15M
Operating profit -65.94%-687.7M-262.90%-138.65M-403.66%-414.42M60.51%85.11M112.37%136.48M113.45%53.02M-186.35%-1.1B-184.54%-394.17M184.14%1.28B85.11%-138.53M
Financing cost 7.36%-321M6.86%-156.97M-7.41%-346.5M-12.66%-168.52M-2.45%-322.58M2.70%-149.58M---314.86M---153.74M--------
Share of profits of associates ---------------------------------6,039.68%-80.84M-7,200.00%-146K
Earning before tax -32.56%-1.01B-254.41%-295.61M-308.87%-760.92M13.62%-83.41M86.88%-186.1M82.38%-96.56M-218.48%-1.42B-295.10%-547.91M178.89%1.2B85.10%-138.68M
Tax 120.29%25.13M99.58%-16K171.81%11.41M-131.95%-3.79M-55.96%4.2M2,185.39%11.85M102.63%9.53M99.59%-568K-1,028.90%-362.93M-451.46%-139.69M
After-tax profit from continuing operations -31.23%-983.56M-239.05%-295.63M-312.03%-749.51M-2.93%-87.19M87.09%-181.91M84.56%-84.71M-268.88%-1.41B-97.03%-548.48M156.43%834.24M68.75%-278.37M
Earning after tax -31.23%-983.56M-239.05%-295.63M-312.03%-749.51M-2.93%-87.19M87.09%-181.91M84.56%-84.71M-268.88%-1.41B-97.03%-548.48M156.43%834.24M68.75%-278.37M
Minority profit -182.75%-27.69M83.59%-487K-163.78%-9.79M-169.34%-2.97M218.58%15.35M146.50%4.28M-21.99%-12.95M-715.87%-9.2M60.42%-10.61M92.25%-1.13M
Profit attributable to shareholders -29.22%-955.88M-250.41%-295.14M-275.00%-739.72M5.35%-84.23M85.87%-197.26M83.50%-88.99M-265.23%-1.4B-94.52%-539.27M158.20%844.85M68.36%-277.24M
Basic earnings per share -14.25%-0.1042-250.00%-0.0364-275.31%-0.09125.45%-0.010485.96%-0.024383.66%-0.011-263.92%-0.17313.86%-0.0673129.10%0.105668.04%-0.07
Diluted earnings per share -14.25%-0.1042-250.00%-0.0364-275.31%-0.09125.45%-0.010485.96%-0.024383.66%-0.011-263.92%-0.17313.86%-0.0673129.10%0.105668.04%-0.07
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIASIASIAS
Audit Opinions --------Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--
Auditor ----National Health Accounting Firm Co., Ltd.--Ernst & Young--Ernst & Young--Ernst & Young--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +4.00%
Sample Name
Sample Code
 +2.86%
4
SINOPEC CORP
00386
+2.22%
5
CNOOC
00883
+1.66%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +46.25%
Sample Name
Sample Code
 +33.47%
Sample Name
Sample Code
 +26.48%
4
Loongson Technology Corporation
688047
+24.63%
5
Rockchip Electronics
603893
+19.54%
View More
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -